Genocea to Present at the Cowen & Company 40th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will …